CIK 0001755237 · Non-accelerated filer<br>Smaller reporting company
Korsana Biosciences, Inc.
Sign in to watch- Ticker
- KRSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 831895370
- Phone
- (781) 516-2325
- Business address
- 203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
- Former names
- Cyclerion Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-22 | Busch Andreas Chief Innovation Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-11-15 | Busch Andreas Chief Innovation Officer | Purchase | +125,000 | $1.82 | $228K | 125,000 |
| 2019-11-08 | Huyett William Chief Financial Officer | Sale | −3,922 | $2.05 | $8K | 74,976 |
| 2019-07-10 | Hecht Peter M Chief Executive Officer | Option exercise | +2,000 | $6.04 | $12K | 225,192 |
| 2019-07-10 | Hecht Peter M Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,000 | 0 | ||
| 2019-06-01 | SCHULMAN AMY W Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-01 | Mendelsohn Michael Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-01 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-01 | Lovell Stephanie Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-01 | Isacson Ole Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-01 | Fanucci Marsha Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-01 | CONRADES GEORGE H Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-01 | Churchwell Kevin Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-04-29 | Busch Andreas Chief Innovation Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2019-04-08 | MCGUIRE TERRANCE Director | Purchase | +604,482 | $16.00 | $9.7M | 604,482 |
| 2019-04-08 | MCGUIRE TERRANCE Director | Purchase | +21,635 | $16.00 | $346K | 21,635 |
| 2019-04-08 | SCHULMAN AMY W Director | Purchase | +604,482 | $16.00 | $9.7M | 604,482 |
| 2019-04-08 | SCHULMAN AMY W Director | Purchase | +21,635 | $16.00 | $346K | 21,635 |
| 2019-04-02 | Currie Mark G President | Purchase | +270,107 | $14.81 | $4.0M | 321,755 |
| 2019-04-01 | Hecht Peter M Chief Executive Officer | Grant or award | +221,736 | 221,736 |
Page 5 of 9 · 167 trades